Humacyte, Inc. (HUMA)
1.02
+0.10
(+11.21%)
USD |
NASDAQ |
May 21, 16:00
1.02
0.00 (0.00%)
After-Hours: 18:49
Humacyte EPS Diluted (Quarterly) : -0.089 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.1813 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| PDS Biotechnology Corp. | -0.1324 |
| Bolt Biotherapeutics, Inc. | -4.311 |
| Entrada Therapeutics, Inc. | -0.9493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.62M |
| Revenue (Quarterly) | 0.495M |
| Total Expenses (Quarterly) | 18.11M |
| Enterprise Value | 220.85M |
| Gross Profit Margin (Quarterly) | -311.7% |
| Profit Margin (Quarterly) | -3.56K% |
| Earnings Yield | -56.34% |
| Normalized Earnings Yield | -65.23 |